Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
09/2003
09/10/2003EP1341920A2 Human elongase genes and uses thereof
09/10/2003EP1341817A2 Tff peptides
09/10/2003EP1341811A2 Orally ingestible preparation of mistletoe lectins and method
09/10/2003EP1341792A2 Amido ether substituted imidazoquinolines
09/10/2003EP1341791A2 Thioether substituted imidazoquinolines
09/10/2003EP1341790A2 Sulfonamido ether substituted imidazoquinolines
09/10/2003EP1341789A2 Aryl ether substituted imidazoquinolines
09/10/2003EP1341782A2 Inhibitors of p38 kinase
09/10/2003EP1341770A1 Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors
09/10/2003EP1341767A2 Imidazole and benzimidazole caspase inhibitors and uses thereof
09/10/2003EP1341754A1 Substituted anthranilic acids
09/10/2003EP1341546A2 Kyberdrug as autovaccines with immune-regulating effects
09/10/2003EP1341542A2 Organic compounds
09/10/2003EP1341539A1 Anti-inflammatory agents
09/10/2003EP1341538A2 Novel medicament compositions
09/10/2003EP1341537A2 Pharmaceutically active isoindoline derivatives
09/10/2003EP1341512A1 Rhinological agents
09/10/2003EP1090023B1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
09/10/2003EP1090021B1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
09/10/2003EP1057827B1 Spiropiperidine derivatives
09/10/2003EP0991650B1 Novel n-benzenesulphonyl-l-proline compounds, preparation method and use in therapy
09/10/2003EP0977553B1 Throat soothing compositions
09/10/2003EP0912518B1 Substituted pyridines as selective cyclooxygenase-2 inhibitors
09/10/2003EP0594732B1 Humanized antibody against cd18
09/10/2003CN1441808A Chemokine receptor modulators, production and use
09/10/2003CN1441801A Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
09/10/2003CN1441798A Thiophene vitamine A
09/10/2003CN1441788A Novel arylethene-sulfonamides compounds
09/10/2003CN1441782A N-oxides as NK1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
09/10/2003CN1441781A Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
09/10/2003CN1441780A Piperidine compounds for use as CCR-3 inhibitors
09/10/2003CN1441776A Novel aryl, alkenyl and alkynl 4-dedimethylamino tetracycline derivatives
09/10/2003CN1441770A Modified forms of pharmacologically active agents and uses therefor
09/10/2003CN1441673A 4,5-dihydro-thiazo-2-ylamine derivatives and their use as NO-synthase inhibitors
09/10/2003CN1440984A Dauricine polysaccharide, its extraction method and the use of medicine with the compound as active component
09/10/2003CN1440980A Mannosan peptide and its prepn and use
09/10/2003CN1440806A Nasosinusitis treating Chinese medicine powder
09/10/2003CN1440785A Composite medicine for treating throat diseases
09/10/2003CN1440760A Dilingquan powder producing process
09/10/2003CN1440759A Composite medicine for treating respirtory system diseases and its prepn process
09/10/2003CN1440755A Laryngopharyngitis treating medicine
09/10/2003CN1120841C Medicine composition and use thereof
09/10/2003CN1120719C Aloes lozenge and preparing method thereof
09/09/2003US6617361 Protocol for prevention of Alzheimer's disease involves stimulating implicit memory; psychotherapeutic or psychological supports; stimulating explicit memory; transfers learned behavior into the implicit memory.
09/09/2003US6617359 4-fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical
09/09/2003US6617352 Compounds and methods for the inhibition of the expression of VCAM-1
09/09/2003US6617345 Cyclooxygenase-2 inhibitor is (5-bromo-2-(4-fluorophenyl )-3-(4-(methylsulfonyl)phey)-thiophene), N-(2-(cyclohexyloxy 4-nitrophenyl)-methanesulfonamide), meloxicam, flosulide or cyclic substituted phenyl sulfones or sulfonamides
09/09/2003US6617336 Treatment of urinary incontinence, venous insufficiency, migraine or gastrointestinal disorders
09/09/2003US6617324 Substituted pyrazoles as p38 kinase inhibitors
09/09/2003US6617317 Boronic ester and acid compositions
09/09/2003CA2263566C Substituted 6,5-hetero-bicyclic derivatives
09/04/2003WO2003072780A1 Novel proteins, dnas thereof and use of the same
09/04/2003WO2003072734A2 Bipolar trans carotenoid salts and their uses
09/04/2003WO2003072720A2 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
09/04/2003WO2003072719A2 Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences
09/04/2003WO2003072704A2 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/04/2003WO2003072601A1 Method for producing hypoallergenic major birch pollen allergens rbet v 1
09/04/2003WO2003072572A1 Beta3-adrenergic receptor agonists
09/04/2003WO2003072569A1 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
09/04/2003WO2003072557A1 5-phenylthiazole derivatives and use as pi3 kinase inhibitors
09/04/2003WO2003072545A1 Cyclic amine compound and ccr3 inhibitory drug containing the same as active ingredient
09/04/2003WO2003072539A1 Phenethanolamine derivatives for treatment of respiratory diseases
09/04/2003WO2003072135A2 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
09/04/2003WO2003072134A1 Diagnostics and remedies for interstitial pneumonia
09/04/2003WO2003072107A1 Substituted pyrimidinones and pyrimidinthiones
09/04/2003WO2003072094A1 Ambroxol for treating painful conditions in the mouth and pharyngeal cavity
09/04/2003WO2003072067A2 Compositions and methods for treating epithelial and retinal tissue diseases
09/04/2003WO2003072060A2 Polypeptide formulation
09/04/2003WO2003072035A2 Compositions and methods for the treatment of immune related diseases
09/04/2003WO2003062209A3 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
09/04/2003WO2003051805A3 Substituted phenyl naphthalenes as estrogenic agents
09/04/2003WO2003048120A3 2-aryl pyrrologpyrimidines for a1 and a3 receptors
09/04/2003WO2003035646A3 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist
09/04/2003WO2003024488A3 Combination of a pde inhibitor and a leukotriene receptor antagonist
09/04/2003WO2003011860A3 2-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-N-[6-(1,1-DIOXO-1λ6-THIOMORPHOLIN-4-YL)-4-(2-METHYL OR 4-FLUORO-2-METHYL SUBSTITUTED)PHENYL-PYRIDIN-3-YL]-N-METHYL-ISOBUTYRAMIDE
09/04/2003WO2003009808A3 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease
09/04/2003WO2002079238A3 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis
09/04/2003WO2002064792A3 Molecules for disease detection and treatment
09/04/2003WO2002052020A3 Regulation of human carboxypeptidase a
09/04/2003WO2002052002A3 Immunomodulatory polynucleotides and methods of using the same
09/04/2003WO2002046389A3 Genes associated with allergic hypersensitivity and mast cell activation
09/04/2003WO2001081622A3 Diagnosis of diseases associated with dna repair
09/04/2003WO2001076451A3 Diagnosis of diseases associated with metabolism
09/04/2003WO2001057261A9 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
09/04/2003US20030167525 Desaturase genes and uses thereof
09/04/2003US20030166945 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
09/04/2003US20030166899 Antiinflammatory agents; antiarthritic agents; anticancer agents
09/04/2003US20030166881 Variations, modulation in gene expression; transgenic animals; skin disorders
09/04/2003US20030166859 Controlling cell proliferation, cell differentiation; anticancer agents
09/04/2003US20030166730 Amide derivatives for the treatment of diseases mediated by cytokines
09/04/2003US20030166725 Compounds active at the glucocorticoid receptor
09/04/2003US20030166723 Gamma-linolenic acid, di-homo-gamma-linolenic acid and derivatives
09/04/2003US20030166716 Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases
09/04/2003US20030166687 Alpha-hydroxy,-amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors
09/04/2003US20030166685 Acid derivatives of benzene useful as anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer
09/04/2003US20030166681 Aminopyrrolidine sulfonamides as serine protease inhibitors
09/04/2003US20030166680 For treating serine protease or dual-serine protease mediated disorders
09/04/2003US20030166655 Acyclic nucleotide phosphodiesterase of type 4 inhibitors; antiinflammatory agents; antiallergens; antiarthritis agents, rheumatic diseases; AIDS; gastrointestinal, respiratory, brain, urogenital disorders
09/04/2003US20030166652 Chemical compounds
09/04/2003US20030166646 Nitric oxide synthase inhibitors such as 4-(morpholin-4-yl methyl)-4,5-dihydro-1,3-thiazol-2-ylamine, administered for prophylaxis of neurodegenerative diseases
1 ... 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 ... 878